LDS/Medical Tests/Malaria, Molecular Detection, Molecular (Procleix Plasmodium Assay)

Malaria, Molecular Detection, Molecular (Procleix Plasmodium Assay)

Malaria is a febrile illness caused by one of five species of the protozoan parasite, Plasmodium (P. malariae, P. vivax, P. falciparum, P. ovale and the recently identified P. knowlesi). Malaria is endemic in most tropical and subtropical climates where it infects over 200 million people annually and causes over 400,000 deaths. The symptoms of malaria are dependent on the Plasmodium sp. involved, the age of the individual and their level of immunity.

P. vivax and P. falciparum are the species most commonly encountered in patients with malaria. P. knowlesi rarely causes infections in humans. Infection with P. falciparum may be associated with fatal complications involving the brain and multiple organs. Infection with multiple species may also be encountered.

Humans acquire malaria via the bite of an infected female Anopheles mosquito. During feeding sporozoites, the infective stage of the parasite, are inoculated into the blood. The sporozoites then invade hepatocytes and erythrocytes, multiply by forming numerous merozoites which are then released to infect more cells when the hepatocytes and erythrocytes die. Patients usually develop symptoms after an incubation period of 7-30 days. The clinical manifestations are the result of large numbers of merozoites in the blood released after the erythrocytic stage. Symptoms include fever with chills, headache, muscle aches, and sometimes hemolytic anemia with jaundice. Untreated P. falciparum infections can lead to cerebral malaria and cause seizures and coma. Older aged individuals, those with poor nutrition, and individuals with immunodeficiency are vulnerable to develop severe disease. Glucose-6 Phosphate Dehydrogenase (G6PD) enzyme deficiency and Sickle Cell Trait are known to provide some protection against malaria.

The examination of Giemsa-stained peripheral blood films is routinely performed for the primary screening and diagnosis of malaria. Although microscopy is fairly sensitive at detecting malaria, species identification can be very difficult even with practiced observers. Molecular detection of the parasite using PCR is an efficient for both diagnosis as well as species identification of malaria.

The only FDA approved test for testing Malaria by molecular is Procleix Plasmodium Assay from Grifols. 

The Procleix Plasmodium Assay is a nucleic acid test (NAT) is a Transcription-Mediated Amplification  (TMA) used to detect the presence of specific ribosomal RNA sequences of five species of Plasmodium parasites that cause malaria in humans (P. falciparum, P. knowlesi, P. malariae, P. ovale, and P. vivax) in whole blood specimens from blood donors to reduce the risk of transfusing infected blood or blood components, even when the donor does not exhibit symptoms and traditional screening techniques are not able to detect the presence of the pathogen, or the antibodies against it.

  • Donor (transfusion and transplant patient) screening for malaria
  • Confirmation of the diagnosis of malaria
  • Useful in species identification of malarial parasite

A positive result indicates the presence of malarial parasite in the blood, confirming malaria.

A negative result indicates the absence of malarial parasite. Negative result rules out the diagnosis of malaria.

Negative (Not detected)

Real-time Polymerase Chain Reaction (PCR), other Nucleic Acid Amplification Technologies.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days.
  • Refrigerated: 7-14 days
  • Frozen: unstable
Complete Blood Count (CBC), Peripheral Blood Smear (PBS) examination, malarial antigen RDT, Giemsa staining of thick and thin blood smear, acridine orange staining of blood film, DNA probe, in vitro cultivation.
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Malaria. StatPearls Publishing [PMID: 31869175]
  • Cold Spring Harb Perspect Med. 2018; 1:a025569 [PMID: 28533315]
  • Denise L. Doolan. Malaria Methods and Protocols. Methods in Molecular Medicine. 2002. Humana Press.Inc